Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
28.09
-4.65 (-14.20%)
At close: Jul 24, 2026, 4:00 PM EDT
27.99
-0.10 (-0.37%)
After-hours: Jul 24, 2026, 7:59 PM EDT

Company Description

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.

The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.

It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers.

Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services.

Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health.

The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.

Hims & Hers Health, Inc.
Hims & Hers Health logo
CountryUnited States
Founded2017
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees2,442
CEOAndrew Dudum

Contact Details

Address:
2269 Chestnut Street, Suite 523
San Francisco, California 94123
United States
Phone415 851 0195
Websitehims.com

Stock Details

Ticker SymbolHIMS
ExchangeNYSE
Stock TypeCommon Stock
Share ClassClass A Shares
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code1773751
CUSIP Number433000106
ISIN NumberUS4330001060
SIC Code8011

Key Executives

NamePosition
Andrew DudumCo-Founder, Chairman and Chief Executive Officer
Oluyemi OkupeChief Financial Officer
Mike ChiChief Operating Officer
Mohamed ElShenawyChief Technology Officer
Soleil Teubner Boughton J.D.Chief Legal Officer and Corporate Secretary
Dr. Patrick Carroll M.D.Global Chief Medical Officer
Deborah M. Autor J.D.Chief Policy Officer and Director
William James NewbySenior Director of Investor Relations
Kathryn H. Beiser B.A., M.S.Chief Communications Officer
Sarah StuartSenior Vice President of People

Latest SEC Filings

DateTypeTitle
Jul 22, 2026144Filing
Jul 17, 20268-KCurrent Report
Jul 6, 2026144Filing
Jul 1, 20268-KCurrent Report
Jun 18, 2026144Filing
Jun 17, 2026144Filing
Jun 17, 2026144Filing
Jun 17, 2026144Filing
Jun 16, 2026144Filing
Jun 15, 20268-KCurrent Report